Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

AI-Driven Real Time Voice Analyzer COVID Screening App Hits Major Milestone of 100,000 Installs in Just Seven Weeks


News provided by

RTVA Inc.

Feb 02, 2024, 07:42 ET

Share this article

Share toX

Share this article

Share toX

RTVA app delivers a fast, accurate, and non-invasive COVID or respiratory illness screening without uncomfortable nasal swabs or painful tests.
RTVA app delivers a fast, accurate, and non-invasive COVID or respiratory illness screening without uncomfortable nasal swabs or painful tests.

The novel app created in partnership with Hematico and the internationally recognized voice analysis research expert Dr. Rita Singh, hits 100,000 installs – a milestone that only 3.4% of the millions of apps on Google Play or Apple Store achieve. It utilizes patent-pending advanced AI algorithms to non-invasively detect respiratory health anomalies quickly and accurately in any language using just a mobile phone.

CABOT, Ark., Feb. 2, 2024 /PRNewswire-PRWeb/ -- RTVA, Inc. and Hematico, LLC, developers of Real Time Voice Analyzer (RTVA) - the first mobile health app to non-invasively screen for COVID and other respiratory health anomalies, announced today the app hit 100,000 installs in just seven weeks. The app is powered by patent-pending AI technology developed by Carnegie Mellon University professor Rita Singh, PhD, an expert in the field of voice analysis research and respiratory illness detection. Dr. Singh has more than 25 years of experience and research in voice analysis. The University of Cambridge and Massachusetts Institute of Technology have complied similar studies. The AI-driven RTVA app is revolutionizing COVID screening and experiencing a surge in popularity with users.

"We're thrilled with the response to the launch of Real Time Voice Analyzer and excited that the app reached 100,000 installs in such a short period of time," said James Muller, CEO of Hematico, LLC. "It has been a tough winter with high levels of COVID and other respiratory viruses circulating, and we are achieving our goal of giving people a non-invasive way to accurately screen themselves and their loved ones for a respiratory illness at any time of day. Information is private, secure and 100% HIPAA compliant. Our app lets people be proactive and take control of managing their health, while quickly letting them know if they should seek further treatment with a healthcare professional or follow CDC-recommended protocols."

"We're thrilled with the response to the launch of Real Time Voice Analyzer and excited that the app reached 100,000 installs in such a short period of time," said James Muller, CEO of Hematico, LLC.

Post this

RTVA delivers a fast, accurate, and non-invasive COVID or respiratory illness screening without uncomfortable nasal swabs or painful tests. Other benefits include:

  • RTVA's AI algorithms can detect influenza and the common cold strains, in addition to COVID-19 and its variants.
  • Uses only the sound of a person's voice, like a doctor using a stethoscope to detect irregularities in vital organs.
  • Delivers reliable results in 5-10 minutes – skip the wait at the waiting room.
  • Screening results have scientifically proven to be more accurate than rapid tests.
  • RTVA's algorithm works with a wide range of vocal sounds but primarily uses vowel sounds due to their consistent performance across different languages and dialects, ensuring accurate results for all users no matter the language spoken.
  • No need to purchase additional accessories or equipment. RTVA works with any smartphone, tablet, or computer with a microphone to record a voice.
  • RTVA is environmentally friendly; No plastics, swabs, packaging, or shipping are needed.

Visit https://realtimevoiceanalyzer.com/ to learn more.

About RTVA Inc.
Discover the groundbreaking Real Time Voice Analyzer, a state-of-the-art technology that harnesses the power of AI and your personal voice biomarkers to detect respiratory illnesses, including COVID-19. The Real Time Voice Analyzer is an extraordinary collaboration that could revolutionize global healthcare. This groundbreaking project combines the scientific discoveries and laboratory research of Dr. Rita Singh, the advanced technology and clinical research expertise of Hematico, and the innovative smartphone app development and distribution capabilities of Real Time Network. This constructive interaction of scientific knowledge, technological advancements, and efficient distribution channels has paved the way for a truly transformative healthcare tool.

Developed by Dr. Rita Singh and a team of researchers from Carnegie Mellon University, Yale University School of Medicine, and MIT, our solution is simple, unintrusive, and offers rapid results with ultimate accuracy. Monitor your health anytime, anywhere, with our convenient smartphone app.

Media Contact

Ria Romano, Publicist, RTVA Inc., 786-290-6413, [email protected], https://realtimevoiceanalyzer.com/

SOURCE RTVA Inc.

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.